4. Brasil. Lei no , de Anvisa reforça alerta para os riscos sanitários provocados pela Lei no 6 ago. ANVISA. Homeopatia esta regulamentada pela lei artigo Política Nacional de Práticas Integrativas para o Sistema Único de Saúde. According Agência Nacional de Vigilância Sanitária (Anvisa – Brazilian Na- tional Health . The Brazilian law /, established the sanitary control to sale of medicines, drugs [5] Brasil. Lei no de 24 de setembro de

Author: Kesida Faejinn
Country: Belgium
Language: English (Spanish)
Genre: Marketing
Published (Last): 14 March 2016
Pages: 205
PDF File Size: 18.71 Mb
ePub File Size: 2.85 Mb
ISBN: 692-7-56291-875-3
Downloads: 43691
Price: Free* [*Free Regsitration Required]
Uploader: Jukinos

According to Resolution n. On the other hand, in the absence of federal law, States have complete legisla- tive competency, that is, the States can supplement federal legislation whenever it is necessary to defend the right to health.

Fernando Aith, Ana Carolina da Cunha, Felipe Castellaro, Darnise Soares, Sueli Dallari no charges, but the company should have authorization to function, allowing it to manufacture or import the drug. There are also speciications related to generic drugs.

Copy of Copy of Seminário de homeopatia by Gustavo Martello on Prezi

The objective is that the pharmaceutical companies should present labels and packaged lealets in the most comprehensible form and the form that is most useful to consumers. For pharmaceutical products, granting of the patent also requires prior approval by the Anvisa46, as described. The objective of this paper is to ofer a broad introduction to the Brazilian Pol- icy on Regulation of Drugs and Medications, presenting the reader with the bases of the regulation currently in force, so as to enable the development of deeper discussions on Brazilian policies, or on the strategic lines of the existing regulation, with a view to its permanent improvement.

The importance of pharmacovigilance. After the technical in- spection, the INPI will issue its decision on whether the application is patent- able or not.

Medicines exempt from registration In Brazil, some kinds of medicines are exempt from registration prior to their anvsia. The law also disrupted Brazil’s historically consolidated national health regulatory system and the rules on health surveillance and registration of medicines 2 2.

Click here to sign up. Once registered, the new medication shall be considered the reference prod- uct, and is a part of a list made available by Anvisa, which qualiies it as a benchmark for quality, safety and eicacy for the records of similar annvisa gener- ic medication in Brazil.

Fernando Aith, Ana Carolina da Cunha, Felipe Castellaro, Darnise Soares, Sueli Dallari is the case of antimicrobial medications, the inappropriate use of which can lead to development, by natural selection, of more resistant strains of bacteria within a population, making the medication which was until then available useless.

  ASTM D4427 PDF

Health Surveillance in Brazil is a federally-shared competency, divided between the federal gov- ernment, the governments of the States, and the municipalities. During pre-registration, it is necessary to present protocols for clinical re- search, in the case of a national new product.

Anfisa Paris convention allowed the signatory countries to adopt their own poli- cies with regard to industrial property in order to favor their economic devel- opment. In the irst case, the prescription, without speciication of a single treatment, authorizes the pharmacist to dispense either a generic or a non-generic drug. Currently, the exercise of health surveillance policy, which includes medicine policy, is done by the SNVS, composed of all institutions of Direct and Indirect Public Administration, in all spheres of government, which perform activities of regulation, control and oversight in health surveillance matters.

Thus, in order to understand the policy regulating drugs and medicines, it is necessary to understand the set of public policies that inlu- ence and make up medicine regulations in Anvixa. A recommendation is a suggestion, a notice, not binding, regarding a topic which the CNS is not competent to deliberate on, but which it considers to be important to national health policy.

However, the formation of Brazilian federalism was always centered on the Union, and though it has been changed over its historical evolution, until today, powers and competencies are centralized at the federal level.

Later, three other ordinances relating to good practices were launched: The pre- scription must contain information concerning the identiication and the domicile of the patient, the product dosage and frequency of treatment lim- ited to daysthe date and signature of the prescriber, his or her domicile and, in the anviss of a Brazilian professional, his or her membership in the Pro- fessional Board.

None of these federated entities can invade the competen- cies of the others, under penalty of violating the constitution, except, of course, for the predictive powers that are common to all, as will be explained below. Pharm Bras ; They in- clude the drugs and medicines registration process, research ethics in clinical trials in human beings, observance of good avnisa, protection of industrial and intellectual property and price controls.

This paper is focused on the regulation of licit, or legal, drugs in Brazil.


Measures for rational use of drugs Drugs and medications have an ambivalent nature. For renewal of registration, RDC n. In the case of generics, Anvisa may also request at any time a new bioequiva- lence or pharmaceutical equivalence study, if the pharmaceutical equivalence between generic and reference is challenged by evidence. State and city-level health regulation institutions Health Surveillance, as the health sector that performs actions that cannot be delegated, and of a preventive nature, regarding health risks to which the pop- 28 Brasil.


They appeared before the regulation of generics and have a diferent legal treatment. In the last year of the ive-year period of the validity of the registration, the company must follow the procedures for renewal, presenting to Anvisa, amongst other documents, proof of sale of the medication in their lifetime, the latest version of the package insert present in commercial packaging; the listing of all changes or inclusions in post-registration occurred during the last period of the validity of its registration; data from Phase IV studies, if any.

In any event, if any irregularities are found during an inspection, and notice is served on the establishment, the process of application of penalties for in- fringement of health rules is begun. Products which are biological, immunotherapical, derived from human plas- ma and blood and phytotherapical are not accepted anvsia similar and must be registered in their own categories.

This document describes the clinical trial to be conducted and provides important information which Anvi- sa should be made aware before the trial commences.

It is a procedure that starts from anviea on the accu- mulation of information about the registration of the medication.

Ministério da Saúde

If accepted, the respective CEP must send var- ious documents that vary depending on the topic of research whether special or not to Conep, which has 60 days to state its position on the matter.

The system required registry and iden- tiication of the notifying party, and also his or her full details of qualiication in the case of professionals in services of the various health bodies and health institutions such as Anvisa, State and Municipal Health Surveillance bodies, State and Municipal Health Departments, Public Health Laboratories original in Portuguese: The question is both technical and political since it could give rise to conlicts between diferent views about innovation.

There shall be a guide for making changes and additions speciic to post-registration for phytotherapical medication, provid- ed for in RE n.

Related Posts